Pathway Genomics
Pathway Genomics Corporation was a San Diego, California clinical laboratory and consumer genetics company, incorporated in 2008 and operating a CLIA-certified, CAP-accredited lab at 6777 Nancy Ridge Drive. It sold DNA-based tests direct to consumers and through clinicians, including the PathwayFit diet-and-fitness panel, SkinFit, Cardiac DNA Insight, the Mental Health DNA Insight and Pain Medication DNA Insight pharmacogenomics panels, the BRCATrue and ColoTrue hereditary cancer-risk tests, and the CancerIntercept Detect and Monitor liquid biopsy assays. Its planned 2010 over-the-counter retail launch drew FDA scrutiny, the FDA wrote to the company in September 2015 over its marketing of CancerIntercept Detect, and in December 2015 it agreed to pay roughly $4M to settle US False Claims Act kickback allegations. IBM's Watson Group invested in the company in 2014, and at CES in January 2016 the two debuted OME, a Watson-powered consumer genomic wellness app. The company later renamed itself Pathway OME; on 2021-01-25 its assets were acquired by investor OME Ventures amid customer complaints and rebranded as OME Wellness, which today trades as a medical weight-loss brand rather than a genomics business. Pathway Genomics never published a developer program, public API, SDK, CLI, or machine-readable specification. Its original 2008 domain pathwaygenomics.com is now delegated to Afternic nameservers and serves a GoDaddy aftermarket parking lander offering the domain for sale, so it is deliberately not wired as a Website pointer. This profile is retained as a historical record; there is no API surface to enrich.
Pathway Genomics is profiled on the APIs.io network. Tagged areas include Company, Genomics, Genetic Testing, Clinical Laboratory, and Precision Medicine.
Kin Score
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.